PL03.06 EA5181: Phase 3 Trial of Concurrent and Consolidative Durvalumab vs Consolidation Durva Alone for Unresectable Stage 3 NSCLC
Authors:
- J.M. VarlottoJVJ.M. Varlotto
- Y. XieYXY. Xie
- N. PennellNPN. Pennell
- K. OettelKOK. Oettel
- C.M. LovlyCLC.M. Lovly
- V. AnagnostouVAV. Anagnostou
- G. SrkalovicGSG. Srkalovic
- N.J. MacklerNMN.J. Mackler
- B.A. FallerBFB.A. Faller
- P.T. DykPDP.T. Dyk
- A.A. ChowdharyACA.A. Chowdhary
- G.M.M. VideticGVG.M.M. Videtic
- 24 October 2025
- journal article
- Published by Elsevier in Journal of Thoracic Oncology
- Vol. 20 (10) , S4-S5